Adaptimmune Therapeutics
ADAP
#8446
Rank
NZ$0.27 B
Marketcap
$1.07
Share price
0.82%
Change (1 day)
34.70%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -$0.89

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.94. In 2022 the company made an earnings per share (EPS) of -$1.80 a decrease over its 2021 EPS that were of -$1.80.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.89-50.71%
2022-$1.80-0%
2021-$1.806.25%
2020-$1.70-27.27%
2019-$2.3329.41%
2018-$1.8020.09%
2017-$1.50-16.73%
2016-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$12.72 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.66 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.97 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.50-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA